Humana Inc.

HUM Healthcare Healthcare Plans

Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024. In the quarter to June 2026, revenue grew 26.2%, EPS grew 27.9%, free cash flow grew 58.5% and total debt rose 13.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

413.16 19.04 −4.41%
Market cap
$51.9B
P/E
38.8×
Fwd P/E
42.9×
Dividend yield
0.86%
F-score
6/9
Altman Z
4.66
Beneish M
−2.29
Dividend safety
61/100

Humana Inc. (HUM) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Humana Inc. (HUM) trades at a P/E ratio of 38.8×. Over the past ten years it has ranged from 10.6× (March 2020) to 55.1× (March 2017); the current reading is higher than 98% of that period. That is above the Healthcare Plans industry median of 25.0× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 26.0× 2.49%
FY2024 25.4× 7.67%
FY2023 23.6× 4.39%
FY2022 22.6× 11.01%
FY2021 20.4× 26.31%
FY2020 16.1× (11.28%)
FY2019 18.2× (22.40%)
FY2018 23.4× 56.16%
FY2017 15.0× (69.81%)
FY2016 49.7× 137.25%

Quarterly newest first

Period P/E ratio Change
Jun 2026 37.3× 101.99%
Mar 2026 18.5× (29.06%)
Dec 2025 26.0× 6.95%
Sep 2025 24.3× 30.01%
42 more quarters

Against its own ten years

Low 10.6× High 55.1×
Ten-year median 20.9×
Current reading's percentile 97

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on HUM